These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14732354)

  • 1. TLK1B is elevated with eIF4E overexpression in breast cancer.
    Norton KS; McClusky D; Sen S; Yu H; Meschonat C; Debenedetti A; Li BD
    J Surg Res; 2004 Jan; 116(1):98-103. PubMed ID: 14732354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer.
    Wolfort R; de Benedetti A; Nuthalapaty S; Yu H; Chu QD; Li BD
    Surgery; 2006 Aug; 140(2):161-9. PubMed ID: 16904965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of TLK1B in elevation and recurrence in doxorubicin-treated breast cancer patients with high eIF4E overexpression.
    Byrnes KW; DeBenedetti A; Holm NT; Luke J; Nunez J; Chu QD; Meschonat C; Abreo F; Johnson LW; Li BD
    J Am Coll Surg; 2007 May; 204(5):925-33; discussion 933-4. PubMed ID: 17481512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
    Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
    Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression.
    Li BD; McDonald JC; Nassar R; De Benedetti A
    Ann Surg; 1998 May; 227(5):756-6l; discussion 761-3. PubMed ID: 9605667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome.
    Li BD; Gruner JS; Abreo F; Johnson LW; Yu H; Nawas S; McDonald JC; DeBenedetti A
    Ann Surg; 2002 May; 235(5):732-8; discussion 738-9. PubMed ID: 11981220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer.
    McClusky DR; Chu Q; Yu H; Debenedetti A; Johnson LW; Meschonat C; Turnage R; McDonald JC; Abreo F; Li BD
    Ann Surg; 2005 Oct; 242(4):584-90; discussion 590-2. PubMed ID: 16192819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer.
    Kleiner HE; Krishnan P; Tubbs J; Smith M; Meschonat C; Shi R; Lowery-Nordberg M; Adegboyega P; Unger M; Cardelli J; Chu Q; Mathis JM; Clifford J; De Benedetti A; Li BD
    J Exp Clin Cancer Res; 2009 Jan; 28(1):5. PubMed ID: 19134194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.
    Holm N; Byrnes K; Johnson L; Abreo F; Sehon K; Alley J; Meschonat C; Md QC; Li BD
    Ann Surg Oncol; 2008 Nov; 15(11):3207-15. PubMed ID: 18719964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of eukaryotic initiation factor 4E is correlated with increased risk for systemic dissemination in node-positive breast cancer patients.
    Yin X; Kim RH; Sun G; Miller JK; Li BD
    J Am Coll Surg; 2014 Apr; 218(4):663-71. PubMed ID: 24491247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma.
    Li BD; Liu L; Dawson M; De Benedetti A
    Cancer; 1997 Jun; 79(12):2385-90. PubMed ID: 9191527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High eIF4E, VEGF, and microvessel density in stage I to III breast cancer.
    Byrnes K; White S; Chu Q; Meschonat C; Yu H; Johnson LW; Debenedetti A; Abreo F; Turnage RH; McDonald JC; Li BD
    Ann Surg; 2006 May; 243(5):684-90; discussion 691-2. PubMed ID: 16633004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.
    Sorrells DL; Meschonat C; Black D; Li BD
    J Surg Res; 1999 Jul; 85(1):37-42. PubMed ID: 10383835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of eIF4E gene amplification in breast cancer by competitive PCR.
    Sorrells DL; Black DR; Meschonat C; Rhoads R; De Benedetti A; Gao M; Williams BJ; Li BD
    Ann Surg Oncol; 1998; 5(3):232-7. PubMed ID: 9607624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of the radioresistance kinase TLK1B is induced by gamma-irradiation through activation of mTOR and phosphorylation of 4E-BP1.
    Sunavala-Dossabhoy G; Fowler M; De Benedetti A
    BMC Mol Biol; 2004 Apr; 5():1. PubMed ID: 15070431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of eIF4e gene amplification and overexpression in benign and malignant tumors of the head and neck.
    Haydon MS; Googe JD; Sorrells DS; Ghali GE; Li BD
    Cancer; 2000 Jun; 88(12):2803-10. PubMed ID: 10870064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A translationally regulated Tousled kinase phosphorylates histone H3 and confers radioresistance when overexpressed.
    Li Y; DeFatta R; Anthony C; Sunavala G; De Benedetti A
    Oncogene; 2001 Feb; 20(6):726-38. PubMed ID: 11314006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome.
    Chen CN; Hsieh FJ; Cheng YM; Lee PH; Chang KJ
    J Surg Oncol; 2004 Apr; 86(1):22-7. PubMed ID: 15048676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
    Zhou S; Wang GP; Liu C; Zhou M
    BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers.
    Sorrells DL; Ghali GE; De Benedetti A; Nathan CO; Li BD
    J Oral Maxillofac Surg; 1999 Mar; 57(3):294-9. PubMed ID: 10077200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.